Related Experiment Video
Updated: Mar 27, 2026

09:37
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
2.2K
Targeting MYC in cancer therapy: RNA processing offers new opportunities
Cheryl M Koh1, Arianna Sabò2, Ernesto Guccione1,3,4
1Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.
Summary
The MYC oncoprotein regulates gene transcription and RNA metabolism. Targeting MYC
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- MYC is a crucial transcription factor involved in cell growth and proliferation.
- Dysregulated MYC expression is a hallmark of many human cancers.
- Understanding MYC's downstream effects is vital for cancer therapy.
Purpose of the Study:
- To elucidate the multifaceted roles of MYC in transcription and RNA metabolism.
- To identify key MYC-dependent processes in tumor cells.
- To explore therapeutic strategies targeting MYC in cancer.
Main Methods:
- Analysis of MYC's direct and indirect modulation of transcription.
- Investigation of MYC's influence on RNA processing, including splicing and stability.
- Review of current and emerging technologies for targeting MYC.
Main Results:
- MYC directly controls transcription initiation, elongation, and mRNA capping.
- MYC indirectly impacts RNA metabolism, affecting splicing, stability, and translation.
- Multiple therapeutic avenues exist for targeting MYC in cancer.
Conclusions:
- MYC is a central regulator of both gene expression and RNA metabolism.
- Targeting MYC offers diverse therapeutic opportunities in oncology.
- Future strategies may involve direct MYC reduction or targeting its functional consequences.
Keywords:
MYCRNAcancer therapypost-transcriptional regulationsplicingsynthetic lethalitytranscriptionMore Related Videos
Related Concept Videos
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies
1.7K
1.7K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Induced Pluripotent Stem Cells
6.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.2K
Mitogens and the Cell Cycle
8.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K

